The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK
Abstract
CD200-CD200R signaling holds microglia in a quiescent state. Parkinson disease (PD) neurodegeneration may be associated with impairment of CD200-CD200R-mediated microglia silencing in the substantia nigra (SN). In this study, an anti-CD200R blocking antibody (ACDR) selectively and significantly enhanced the susceptibility of dopaminergic neurons to neurotoxicity induced by rotenone (Rot) and iron (Ir) in mesencephalic neuron/glia cultures. Microglia were shown to mediate dopaminergic neurotoxicity induced by ACDR/Rot (combination of ACDR and Rot) and ACDR/Ir (combination of ACDR and Ir). ACDR significantly enhanced the microglial activation induced by Rot and Ir in neuron/glia cultures. NADPH oxidase-mediated superoxide generation was a key contributor to dopaminergic neurotoxicity induced by ACDR/Rot and ACDR/Ir. p38 MAPK contributed to NADPH oxidase activation induced by ACDR/Rot and ACDR/Ir. Interestingly, there were a decrease in CD200 expression (mRNA and protein) and an enhancement of microglial response (MHCII mRNA and ICAM-1 protein) in the rat SN with aging. ICAM-1 expression was significantly inversely correlated with CD200 expression. These results strongly indicate the participation of SN CD200-CD200R dysfunction in the etiopathogenesis of PD and provide a new insight into the molecular mechanisms underlying the involvement of aging in PD and help to elucidate the mechanisms of the combined involvement of immune/inflammatory factors, environmental substances, and aging in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in the absence of this interaction, microglia become reactive and excessively proliferative”
From Culture shock: microglial heterogeneity, activation, and disrupted single-cell microglial networks in vitro (2022) · cites this paper as [32]
In the citing paper
“the binding of neuronal CD200 to its microglial receptor CD200R is necessary for restricting microglial activation in disease models including rotenone neurotoxicity [32] and Toxoplasma encephalitis [33]”
From Culture shock: microglial heterogeneity, activation, and disrupted single-cell microglial networks in vitro (2022) · cites this paper as [32]
In the citing paper
“In rat PD models, both deficiency CX3CL1 or CX3CR1 as well as the dysfunction of CD200-CD200R signaling have been shown to increase microglial activation and the degeneration of DA neurons (Wang et al., 2011; Zhang et al., 2011).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Wang et al., 2011
Citations
Cites
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,628
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Self-citationWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022
Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881
Cited by
Sorted by citations
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza‐Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 750
Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 605
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
Olfaction in Parkinson's disease and related disorders
Doty, R. L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.026 · Cited by 461
Insulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 340
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306
Sánchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero‐Ramos, M. (2013) · ASN NEURO · doi:10.1042/an20120066 · Cited by 246
Hart, A. D., Wyttenbach, A., Hugh Perry, V., & Teeling, J. L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.006 · Cited by 230
Old Maids: Aging and Its Impact on Microglia Function
Koellhoffer, E. C., McCullough, L. D., & Ritzel, R. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040769 · Cited by 213
Inflammation in Parkinson's Disease
Tüfekçi, K. U., Meuwissen, R. L. J., Genç, Ş., & Genç, K. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 205
Immune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 193
Oxidative Stress and Microglial Cells in Parkinson's Disease
Peterson, L. J., & Flood, P. M. (2012) · Mediators of Inflammation · doi:10.1155/2012/401264 · Cited by 167
Zhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154
“We also found that blocking CD200-CD200R engagement dramatically exacerbates dopaminergic neurodegeneration in a primary neuron/ microglia co-culture system [41].”
BackgroundResultSelf-citationThe immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 151
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.
Jha, S. K., Jha, N. K., Kar, R., Ambasta, R. K., & Kumar, P. (2015) · Europe PMC (PubMed Central) · Cited by 143
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Liu, C., Wang, X., Liu, C., & Zhang, H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 147
Self-citationTargeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors
Surace, M. J., & Block, M. L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1015-4 · Cited by 134
Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation
Manich, G., Recasens, M., Valente, T., Almolda, B., González, B., & Castellano, B. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.030 · Cited by 130
P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
Jiang, T., Hoekstra, J., Heng, X., Kang, W., Ding, J., Liu, J., Chen, S., & Zhang, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.015 · Cited by 123
Self-citationZawada, W. M., Banninger, G. P., Thornton, J., Marriott, B., Cantu, D., Rachubinski, A. L., Das, M., Griffin, W. S. T., & Jones, S. M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-129 · Cited by 125
Updates on immunity and inflammation in Parkinson disease pathology
Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 118
Protective Microglia and Their Regulation in Parkinson’s Disease
Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 123
Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis
Ye, Q., Huang, B., Zhang, X., Zhu, Y., & Chen, X. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-156 · Cited by 100
Interaction between NADPH ‐oxidase and R ho‐kinase in angiotensin II ‐induced microglial activation
Rodriguez-Perez, A. I., Borrajo, A., Rodríguez‐Pallares, J., Guerra, M. J., & Labandeira-García, J. L. (2014) · Glia · doi:10.1002/glia.22765 · Cited by 98
Palasz, E., Niewiadomski, W., Gasiorowska, A., Wysocka, A., Stepniewska, A., & Niewiadomska, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01143 · Cited by 95
Flierl, A., Oliveira, L. M. A., Falomir‐Lockhart, L. J., Mak, S. K., Hesley, J., Soldner, F., Arndt‐Jovin, D. J., Jaenisch, R., Langston, J. W., Jovin, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112413 · Cited by 87
L’Episcopo, F., Tirolo, C., Serapide, M. F., Caniglia, S., Testa, N., Leggio, L., Vivarelli, S., Iraci, N., Pluchino, S., & Marchetti, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00012 · Cited by 85
Chamera, K., Trojan, E., Szuster-Głuszczak, M., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191113101629 · Cited by 82
L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Morale, M. C., Serapide, M. F., Pluchino, S., & Marchetti, B. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt053 · Cited by 83
Xu, H., Wang, Y., Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00455 · Cited by 82
Self-citationSun, H., He, X., Tao, X., Hou, T., Chen, M., He, M., & Liao, H. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01845-x · Cited by 77
Varnum, M. M., Kiyota, T., Dixie, K. L. I., Ikezu, S., & Ikezu, T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.027 · Cited by 77
Cadiz, M. P., Jensen, T. D., Sens, J. P., Zhu, K., Song, W.-M., Zhang, B., Ebbert, M., Chang, R., & Fryer, J. D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00531-1 · Cited by 73
Buga, A.-M., Napoli, M. D., & Popa‐Wagner, A. (2013) · Biogerontology · doi:10.1007/s10522-013-9465-0 · Cited by 73
Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K+ channel
Wu, S.-Y., Chen, Y., Tsai, S., Wu, S., Shih, Y., Jiang‐Shieh, Y., Yang, T.-T., & Kuo, Y. (2016) · Scientific Reports · doi:10.1038/srep22864 · Cited by 68
Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_356 · Cited by 65
Popa‐Wagner, A., Petcu, E. B., Căpitănescu, B., Hermann, D. M., Radu, E., & Greșiță, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111312 · Cited by 71
Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 65
Interplay of glia activation and oxidative stress formation in fluoride and aluminium exposure
Akinrinade, I. D., Memudu, A. E., Ogundele, O. M., & Ajetunmobi, O. I. (2014) · Pathophysiology · doi:10.1016/j.pathophys.2014.12.001 · Cited by 62
Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities
Lyu, J., Jiang, X., Leak, R. K., Shi, Y., Hu, X., & Chen, J. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00857-2 · Cited by 63
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
CD200R1 and CD200 expression are regulated by PPAR‐γ in activated glial cells
Dentesano, G., Serratosa, J., Tusell, J. M., Ramon-Cañellas, P., Valente, T., Saura, J., & Solà, C. (2014) · Glia · doi:10.1002/glia.22656 · Cited by 62
Chamera, K., Kotarska, K., Szuster-Głuszczak, M., Trojan, E., Skórkowska, A., Pomierny, B., Krzyżanowska, W., Bryniarska, N., & Basta‐Kaim, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01923-0 · Cited by 57
The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain
Shrivastava, K., González, P., & Acarín, L. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23062 · Cited by 57
Sutherland, T. C., & Geoffroy, C. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00190 · Cited by 56
Bayo-Olugbami, A., Nafiu, A. B., Amin, A., Ogundele, O. M., Lee, C. C., & Owoyele, B. V. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1815331 · Cited by 50
Yu, L., Wang, X., Chen, H.-Q., Yan, Z., Wang, M., & Li, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00657 · Cited by 44
Self-citationWang, X., Guan, Q., Wang, M., Liu, Y., Bai, J., Yan, Z., Zhang, Y., & Liu, Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s81539 · Cited by 42
Self-citationToxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone
Harris, G., Eschment, M., Orozco, S. P., McCaffery, J. M., Maclennan, R., Severín, D., Leist, M., Kleensang, A., Pamies, D., Maertens, A., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2250-8 · Cited by 42
Guan, Q., Wang, M., Chen, H.-Q., Yang, L., Yan, Z., & Wang, X. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.011 · Cited by 39
Self-citationRole of Vitamin E and the Orexin System in Neuroprotection
Torre, M. E. L., Villano, I., Monda, M., Messina, A., Cibelli, G., Valenzano, A. A., Pisanelli, D., Panaro, M. A., Tartaglia, N., Ambrosi, A., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11081098 · Cited by 37
Walker, D. G., Lue, L.-F., Tang, T. M., Adler, C. H., Caviness, J. N., Sabbagh, M. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.007 · Cited by 33
Tian, Y., Cao, Y., Chen, R., Jing, Y., Xia, L., Zhang, S., Xu, H., & Su, Z. (2020) · Clinical Science · doi:10.1042/cs20200553 · Cited by 33
Self-citationZhao, W., Liu, Z., Wu, J., Liu, A., & Yan, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01343 · Cited by 37
Chamera, K., Szuster-Głuszczak, M., Trojan, E., & Basta-Kaim, A. (2020) · Cells · doi:10.3390/cells9071676 · Cited by 31
Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Awamlh, S. A. H. A., Wareham, L. K., Risner, M. L., & Calkins, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094672 · Cited by 30
Chamera, K., Trojan, E., Kotarska, K., Szuster-Głuszczak, M., Bryniarska, N., Tylek, K., & Basta‐Kaim, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041558 · Cited by 25
Qian, H., Gao, F., Wu, X., Lin, D., Huang, Y., Chen, A., Deng, J., Gong, C., Chen, X., & Zheng, X. (2023) · Inflammation Research · doi:10.1007/s00011-023-01804-1 · Cited by 25
CD200-CD200R Interaction: An Important Regulator After Stroke
Zhao, X., Li, J., & Sun, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00840 · Cited by 23
Liu, Y., Yu, L., Xu, Y., Tang, X., & Wang, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02023-9 · Cited by 21
Self-citationDapul, H. R., Park, J., Zhang, J., Lee, C., Daneshmand, A., Lok, J. M., Ayata, C., Gray, T., Scalzo, A., Qiu, J., et al. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2536 · Cited by 20
Self-citationChen, H.-Q., Wang, X., Wang, M., Liu, Y., Yan, Z., Zhang, Y., & Liu, Z. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00206 · Cited by 19
Self-citationControl of JNK for an activation of NADPH oxidase in LPS-stimulated BV2 microglia
Han, J. E., & Choi, J. W. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0415-1 · Cited by 19
Bal‐Price, A., Leist, M., Schildknecht, S., Monnet‐Tschudi, F., Paini, A., & Terron, A. (2018) · OECD series on adverse outcome pathways · doi:10.1787/b46c3c00-en · Cited by 22
Li, S., Wei, D., Mao, Z., Chen, L., Yan, X., Li, Y., Dong, S., & Wang, D. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.05.010 · Cited by 17
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
Singh, V., Kushwaha, S., Ansari, J. A., Gangopadhyay, S., Mishra, S. K., Dey, R. K., Giri, A. K., Patnaik, S., & Ghosh, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101521 · Cited by 14
Guan, Q., Jin, L., Li, Y., Han, H., Zheng, Y., & Nie, Z. (2015) · Topics in Stroke Rehabilitation · doi:10.1179/1074935714z.0000000048 · Cited by 14
Qi, M., Qiu, Y., Zhou, X., Tian, K., Zhou, K., Sun, F., Yue, B., Chen, F., Zha, D., & Qiu, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.141 · Cited by 12
Lancemaside A inhibits microglial activation via modulation of JNK signaling pathway
Jeong, Y., Jung, J.-S., Le, T. K. V., Kim, D., & Kim, H.-S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.049 · Cited by 12
Le, C., Hao, X., Li, J., Zhong, J., Lin, H., Zhou, Y., Travis, Z. D., Tong, L., & Gao, F. (2019) · Cell Transplantation · doi:10.1177/0963689719857655 · Cited by 13
Jensen, S. K., & Yong, V. W. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12093 · Cited by 14
Gomes, P. X. L., de Oliveira, G. V., de Araújo, F. Y. R., Viana, G. S. D. B., de Sousa, F. C. F., Hyphantis, T. N., Grunberg, N. E., Carvalho, A. F., & Macêdo, D. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2799-5 · Cited by 12
Computational Strategies to Identify New Drug Candidates against Neuroinflammation
Pavan, M., Bassani, D., Bolcato, G., Bissaro, M., Sturlese, M., & Moro, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220208095122 · Cited by 11
Effects of long-term atorvastatin treatment on cardiac aging
Han, L., Li, M., & Liu, X. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1208 · Cited by 11
Inhibition of Sirtuin 2 exerts neuroprotection in aging rats with increased neonatal iron intake
Liu, Z., Wang, X., Wang, M., Liu, Y., Bai, J., Yan, Z., & Zhang, Y. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.145361 · Cited by 10
Self-citationCD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
Comella-Bolla, A., Valente, T., Miguez, A., Brito, V., Ginés, S., Solà, C., Straccia, M., & Canals, J. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224901 · Cited by 10
Tang, Y., & Le, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_4 · Cited by 10
The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson’s disease
Lin, S., Shu, Y., Shen, R., Zhou, Y., Pan, H., He, L., Fang, F., Zhu, X., Wang, X., Wang, Y., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03231-3 · Cited by 9
Self-citationSong, J., Pan, W., Sun, Y., Han, J. D. J., Shi, W., & Liao, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.038 · Cited by 7
The History, Status, Gaps, and Future Directions of Neurotoxicology in China
Cai, T., Luo, W., Ruan, D., Wu, Y., Fox, D. A., & Chen, J. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1409566 · Cited by 7
Microglia heterogeneity and therapeutic strategies in Parkinson’s disease
Tian, J., Liu, X., Wang, Z., Shi, X., Dai, C., & Yang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739341 · Cited by 6
Analysis of the Impact of CD200 on Neurodegenerative Diseases
Miller, A., Brian, F., Downer, E. J., Lyons, A., Henrich‐Noack, P., Nolan, Y. M., & Marina, A. (2011) · InTech eBooks · doi:10.5772/32003 · Cited by 5
CD200R1 Contributes to Successful Functional Reinnervation after a Sciatic Nerve Injury
Pannunzio, B., Amo‐Aparicio, J., Julián, C., López‐Vales, R., Peluffo, H., & Lago, N. (2022) · Cells · doi:10.3390/cells11111786 · Cited by 5
Pérez-Boyero, D., de la Mata, A., Castillo-Sanchez, J., Reverte, I., Yanguas‐Casás, N., Ávila-Zarza, C. A., Valero, J., Alonso, J. R., Arévalo, M., Ragozzino, D., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106248 · Cited by 4
Hsu, C., Hsu, Y.-Y., Chang, B.-M., Raffensperger, K. V., Kadden, M., Ton, H. T., Ette, E.-A., Lin, S., Brooks, J., Burke, M., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07926-y · Cited by 7
Sharallah, O. A., Malakar, V. K., Salama, A. E., Elmaaz, S. M., Daba, S. A., & Poddar, N. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01702-0 · Cited by 3
Hu, Y., Wei, T., Gao, S., Gao, N., Chen, L., & Cheng, Q. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102381 · Cited by 3
Parkinson's Disease Involving Glial Cell Dysfunction
Oukhrib, M., Tamegart, L., Ghachi, H. E., Haj-Khlifa, A., Hamdan, Y. A., Maloui, A. B., Gamrani, H., & Chraa, M. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch009 · Cited by 1
Wang, M., Li, T., Liang, K., Chen, Z., Lei, Y., Zhao, J., Tang, X., Xie, Y., Guan, Q., Zhao, X.-F., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116883 · Cited by 1
Self-citationMead, E. (2012) · UCL Discovery (University College London) · Cited by 1
Inflammation in Parkinson’s Disease: Causes and Consequences
Louise, M., Toulouse, A., & Yvonne, M. (2012) · InTech eBooks · doi:10.5772/18184
CD200: A Novel Therapeutic Target for Chronic Lymphocytic Leukemia
Wong, K. K. W. (2013) · TSpace (University of Toronto)
The Impact of Aging and Age-Related Comorbidities on Stroke Outcome in Animal Models and Humans
Popa‐Wagner, A., Popescu-Drigă, M. V., & Glăvan, D. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-54564-2_12
Patro, N., Kushwaha, S. S., & Patro, I. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_20
Liu, Y., Yu, L., Xu, Y., Tang, X., & Wang, X. (2020) · Figshare · doi:10.6084/m9.figshare.13245320
Self-citationLiu, Y., Yu, L., Xu, Y., Tang, X., & Wang, X. (2020) · Figshare · doi:10.6084/m9.figshare.13245329
Self-citationCadiz, M. P., Jensen, T. D., Sens, J. P., Zhu, K., Song, W.-M., Zhang, B., Ebbert, M., Chang, R. R., & Fryer, J. D. (2022) · Figshare · doi:10.6084/m9.figshare.19445728
Metadata
- Authors
- Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D.
- Affiliations
- Chinese Academy of Sciences (CN)
- Shanghai Jiao Tong University (CN)
- University of Nebraska Medical Center (US)
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 50
- Issue
- 9
- Pages
- 1094-1106
- ISSN
- 0891-5849 (ISSN-L)
- OpenAlex
- W2078755005
- Cited by
- 108
- References
- 62
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 8 · 2021: 6 · 2020: 16 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 7 · 2014: 10 · 2013: 5 · 2012: 11
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, dopaminergic neuron loss, substantia nigra, rotenone, iron neurotoxicity, NADPH oxidase, superoxide, p38 MAPK, aging, ICAM-1, MHC class II, microglial activation
- MeSH terms
- Aging, Animals, Cells, Cultured, Dopamine, Iron, Mesencephalon, Neurons, Parkinson Disease, Receptors, Immunologic, Rotenone, Superoxides, Antigens, CD, Gene Expression, Polymerase Chain Reaction, Rats, Sprague-Dawley, Microglia, Intercellular Adhesion Molecule-1, Cell Culture Techniques, Antibodies, Blocking, NADPH Oxidases, p38 Mitogen-Activated Protein Kinases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
